Posts with tag: web applications
Abbott Laboratories (ABT) posts Q4 sales in line with expectations, with 7.2% year-on-year growth to $10.97 billion. Its adjusted EPS of $1.34 also meets consensus estimates. Read our full research report to assess if now is the right time to buy ABT.
Published on: January 31, 2025, 08:00 PM UTC